Drug intelligence / Profile preview

Vinylsulfonic acid

Development stage: Preclinical
Modality: Small Molecules

Overview

Vinylsulfonic acid (VSA) is an organic chemical compound primarily utilized as a monomer in the synthesis of various polymers and hydrogels. These resulting materials, often poly(vinylsulfonic acid) or its sodium salt, are explored for a wide range of applications, particularly in biomedical fields and materials science. Its sulfonic acid functional group imparts properties such as negative charge density and hydrophilicity, which are crucial for its functions in drug delivery systems, wound dressings, antifouling membranes, and adsorption technologies.

Targets

BMP2 (Bone morphogenetic protein 2)

Beyond the preview

Go deeper on Vinylsulfonic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vinylsulfonic acid.

Explore the full profile